# FDA 483 - Comparative Biosciences, Inc - May 17, 2019

Source: https://www.globalkeysolutions.net/records/483/comparative-biosciences-inc/a65edc9a-f357-40d5-80bb-3a06625345ec

> FDA 483 for Comparative Biosciences, Inc on May 17, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Comparative Biosciences, Inc
- Inspection Date: 2019-05-17
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Comparative Biosciences, Inc.'s nonclinical laboratory in Sunnyvale, CA, revealed significant deficiencies in the labeling of test and control articles, as well as laboratory reagents. Inspectors observed multiple instances where required information, such as expiration dates and lot numbers, was missing from storage containers. These findings indicate potential non-compliance with Good Laboratory Practice regulations concerning material identification and control.

## Related Documents

- [483 - 2024-07-30](https://www.globalkeysolutions.net/records/483/comparative-biosciences-inc/17ad7641-5177-4b8d-8995-fa0ea23668a8)

## Related Officers

- [Investigator ](https://www.globalkeysolutions.net/people/dustin-tran/52b41643-a5f9-4b2e-8da4-24beca42b1cd)

Company: https://www.globalkeysolutions.net/companies/comparative-biosciences-inc/c0722afa-cde7-48f7-a4d3-630d5c827079

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b